Global Parenteral Drugs to Attain Market Valuation of US$ 802 Bn
The global parenteral drugs market - which was valued at market estimated at US$ 451 Bn in 2019 - is forecasted to expand at a healthy pace during the forecast period (2019 to 2029), according to a new market study by XploreMR. The growth of the market is predominantly attributed to penetration of automation technologies in the pharmaceutical landscape, coupled with increased government spending on the development of biological drugs.
Furthermore, the U.S. Food and Drug Administration (FDA) has recommended the usage of automation technologies in the production of drugs to expedite production, which is bestowing lucrative revenue opportunities to market players. Moreover, manufacturers of parenteral drugs are adopting a single-use strategy for antibodies, proteins, cell therapy, vaccines, and gene therapy, leveraging the growing consumer demand.
Besides, the market players are focusing on producing drugs with superior quality and are incorporating Quality by Design (QbD) to achieve the same. On the back of the aforementioned factors, the global parenteral drugs market will surge past a valuation of US$ 802 Bn by the end of 2029.
Parenteral Drugs Market – Report Scope
XploreMR recently published a market study on the global market for parenteral drugs. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities, and restraints, as well as detailed information about the parenteral drugs market structure. The market study presents exclusive information about how the parenteral drugs market will grow during the forecast period of 2019-2029.
Key indicators of market growth, which include year-on-year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in XploreMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the parenteral drugs market during the forecast period.
The study is relevant for stakeholders in the parenteral drugs market, including, manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the parenteral drugs market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in XploreMR’s study.
Parenteral Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029Buy Now
Custom Market Research Services
xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough
Why Choose XploreMR
Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
Global Market Study on Cloud-based Drug Discovery Platforms: Pharmaceutical Vendors Projected to be the Most Attractive End User Segment Through 2025
About this Report Cloud has proliferated key aspects of business across multiple industries and the healthcare industry is no exception. The facilitation of drug discovery through the cloud is one of ...
Atherosclerosis Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027
Atherosclerosis Drugs Market – Scope of the Report The study on the atherosclerosis drugs market is an exclusive report published by XploreMR, which brings to the fore crucial parameters that a ...